MA31324B1 - Composés contenant de l'azote tricyclique utilisés en tant qu'agents antibactériens - Google Patents
Composés contenant de l'azote tricyclique utilisés en tant qu'agents antibactériensInfo
- Publication number
- MA31324B1 MA31324B1 MA32296A MA32296A MA31324B1 MA 31324 B1 MA31324 B1 MA 31324B1 MA 32296 A MA32296 A MA 32296A MA 32296 A MA32296 A MA 32296A MA 31324 B1 MA31324 B1 MA 31324B1
- Authority
- MA
- Morocco
- Prior art keywords
- containing compounds
- compounds use
- tricyclic nitrogen
- antibacterials
- use antibacterials
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
L'invention concerne des composés contenant de l'azote tricyclique et leur utilisation en tant qu'antibactériens. Z1 et z2 sont indépendamment choisis parmi ch et n.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0707705A GB0707705D0 (en) | 2007-04-20 | 2007-04-20 | Compounds |
GB0720569A GB0720569D0 (en) | 2007-10-19 | 2007-10-19 | Compounds |
GB0805311A GB0805311D0 (en) | 2008-03-20 | 2008-03-20 | Compounds |
PCT/EP2008/054621 WO2008128942A1 (fr) | 2007-04-20 | 2008-04-16 | Composés contenant de l'azote tricyclique utilisés en tant qu'agents antibactériens |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31324B1 true MA31324B1 (fr) | 2010-04-01 |
Family
ID=39580226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32296A MA31324B1 (fr) | 2007-04-20 | 2009-10-21 | Composés contenant de l'azote tricyclique utilisés en tant qu'agents antibactériens |
Country Status (32)
Country | Link |
---|---|
US (1) | US8389524B2 (fr) |
EP (1) | EP2137196B1 (fr) |
JP (1) | JP5389013B2 (fr) |
KR (1) | KR101567096B1 (fr) |
CN (1) | CN101687887B (fr) |
AR (1) | AR066111A1 (fr) |
AT (1) | ATE483717T1 (fr) |
AU (1) | AU2008240764C1 (fr) |
BR (1) | BRPI0810064B8 (fr) |
CA (1) | CA2684659C (fr) |
CL (1) | CL2008001122A1 (fr) |
CO (1) | CO6251368A2 (fr) |
CR (2) | CR11123A (fr) |
CY (1) | CY1111248T1 (fr) |
DE (1) | DE602008002912D1 (fr) |
DK (1) | DK2137196T3 (fr) |
DO (1) | DOP2009000240A (fr) |
EA (1) | EA015821B1 (fr) |
HK (1) | HK1138000A1 (fr) |
HR (1) | HRP20100574T1 (fr) |
IL (1) | IL201204A0 (fr) |
MA (1) | MA31324B1 (fr) |
MX (1) | MX2009011317A (fr) |
MY (1) | MY149347A (fr) |
NZ (1) | NZ579877A (fr) |
PE (1) | PE20090274A1 (fr) |
PL (1) | PL2137196T3 (fr) |
PT (1) | PT2137196E (fr) |
SI (1) | SI2137196T1 (fr) |
TW (1) | TWI431006B (fr) |
UY (1) | UY31038A1 (fr) |
WO (1) | WO2008128942A1 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2626641A1 (fr) * | 2005-10-21 | 2007-07-19 | Glaxo Group Limited | Composes |
EP1847543A1 (fr) | 2006-04-19 | 2007-10-24 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dihydrothienopyrimidines pour le traitement de maladies inflammatoires |
GB0608263D0 (en) | 2006-04-26 | 2006-06-07 | Glaxo Group Ltd | Compounds |
EP2205609B1 (fr) | 2007-10-19 | 2017-03-29 | Boehringer Ingelheim International GmbH | Composés pipérazino-dihydro-thiénopyrimidine substituées par un hétérocycle |
NZ585346A (en) | 2007-10-19 | 2011-09-30 | Boehringer Ingelheim Int | Substituted piperidino-dihydrothienopyrimidines |
US8486948B2 (en) | 2007-10-19 | 2013-07-16 | Boehringer Ingelheim International Gmbh | Piperazinodihydrothienopyrimidine derivatives |
US8349828B2 (en) | 2008-02-20 | 2013-01-08 | Actelion Pharmaceuticals Ltd. | Azatricyclic antibiotic compounds |
EP2300477A1 (fr) * | 2008-05-23 | 2011-03-30 | Glaxo Group Limited | Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens |
KR20110016947A (ko) * | 2008-05-23 | 2011-02-18 | 글락소 그룹 리미티드 | 트리시클릭 질소 함유 화합물 및 항박테리아제로서의 그의 용도 |
RU2530884C2 (ru) | 2008-10-07 | 2014-10-20 | Актелион Фармасьютиклз Лтд | Трициклические оксазолидиноновые антибиотические соединения |
JP2012505866A (ja) * | 2008-10-17 | 2012-03-08 | グラクソ グループ リミテッド | 抗菌剤として使用される三環式窒素化合物 |
CA2749163A1 (fr) | 2009-01-14 | 2010-07-22 | The Salk Institute For Biological Studies | Methodes de criblage et composes utiles dans la protection contre les maladies amyloides |
AR076222A1 (es) | 2009-04-09 | 2011-05-26 | Actelion Pharmaceuticals Ltd | Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen |
TW201130854A (en) | 2009-12-22 | 2011-09-16 | Bayer Schering Pharma Ag | Pyridinone derivatives and pharmaceutical compositions thereof |
EP2566329B1 (fr) | 2010-05-04 | 2020-09-09 | Alkermes Pharma Ireland Limited | Procédé de synthèse de lactames oxydés |
US20130059866A1 (en) | 2011-08-24 | 2013-03-07 | Boehringer Ingelheim International Gmbh | Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
US9802954B2 (en) | 2011-08-24 | 2017-10-31 | Boehringer Ingelheim International Gmbh | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma |
CN103113291B (zh) * | 2013-02-04 | 2015-03-04 | 浙江大学 | 一种3位烯基吡啶衍生物的合成方法 |
JP6453216B2 (ja) * | 2013-07-23 | 2019-01-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ縮合環化合物 |
SG11201700566SA (en) * | 2014-08-22 | 2017-03-30 | Glaxosmithkline Ip Dev Ltd | Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection |
MA45463A (fr) * | 2016-06-22 | 2019-05-01 | Univ Vanderbilt | Modulateurs allostériques positifs du récepteur muscarinique de l'acétylcholine m4 |
CA3060545A1 (fr) | 2017-04-17 | 2018-10-25 | Ohio State Innovation Foundation | Inhibiteurs de topoisomerase de type ii et procedes de production et d'utilisation de ces derniers |
BR112021018815A2 (pt) | 2019-04-03 | 2022-03-03 | Glaxosmithkline Ip Dev Ltd | Gepotidacina para uso no tratamento de infecções bacterianas do trato urinário |
WO2021004910A1 (fr) | 2019-07-05 | 2021-01-14 | Glaxosmithkline Intellectual Property Development Limited | Combinaison pour le traitement d'infections provoquées par mycoplasma genitalium |
EP4125905A1 (fr) | 2020-04-02 | 2023-02-08 | GlaxoSmithKline Intellectual Property Development Limited | Régime de traitement d'une infection par neisseria gonorrhoeae par gépotidacine |
EP4143188A1 (fr) * | 2020-04-29 | 2023-03-08 | GlaxoSmithKline Intellectual Property Development Limited | Formes cristallines de gépotidacine |
CN111494241B (zh) * | 2020-06-01 | 2023-03-24 | 湖北洁世达环保科技有限公司 | 一种纸巾柔润保湿液 |
EP4288035A1 (fr) | 2021-02-05 | 2023-12-13 | GlaxoSmithKline Intellectual Property Development Limited | Formulations en doses solides administrées par voie orale |
CA3240991A1 (fr) | 2022-01-21 | 2023-07-27 | Nicole SCANGARELLA-OMAN | Gepotidacine et vancomycine a utiliser dans le traitement d'une infection provoquee par staphylococcus saprophyticus |
EP4316463A1 (fr) | 2022-08-02 | 2024-02-07 | GlaxoSmithKline Intellectual Property Development Limited | Nouvelle formule |
WO2024068524A1 (fr) | 2022-09-26 | 2024-04-04 | Glaxosmithkline Intellectual Property Development Limited | Gépotidacine destinée à être utilisée dans le traitement de la prostatite bactérienne |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403610B1 (en) | 1999-09-17 | 2002-06-11 | Aventis Pharma S.A. | Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them |
US6525049B2 (en) | 2000-07-05 | 2003-02-25 | Pharmacia & Upjohn Company | Pyrroloquinolones as antiviral agents |
US6624159B2 (en) | 2000-07-12 | 2003-09-23 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
PL366335A1 (en) | 2000-07-26 | 2005-01-24 | Smithkline Beecham P.L.C. | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
US6603005B2 (en) | 2000-11-15 | 2003-08-05 | Aventis Pharma S.A. | Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them |
GB0031088D0 (en) | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
EP1345903A1 (fr) | 2000-12-21 | 2003-09-24 | Ciba SC Holding AG | Formes cristallines de sodium de cerivastatine |
GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
US6602884B2 (en) | 2001-03-13 | 2003-08-05 | Aventis Pharma S.A. | Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them |
GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0118238D0 (en) | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
AU2002350217A1 (en) | 2001-12-04 | 2003-06-17 | Bristol-Myers Squibb Company | Glycinamides as factor xa inhibitors |
EP1470131A2 (fr) | 2002-01-29 | 2004-10-27 | Glaxo Group Limited | Composes aminopiperidine, leur procede de preparation et compositions pharmaceutiques les contenant |
US7312212B2 (en) | 2002-01-29 | 2007-12-25 | Glaxo Group Limited | Aminopiperidine derivatives |
TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
TW200409637A (en) | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
GB0217294D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicaments |
FR2844268B1 (fr) | 2002-09-11 | 2004-10-22 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent |
FR2844270B1 (fr) | 2002-09-11 | 2006-05-19 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent |
ATE463494T1 (de) | 2002-10-10 | 2010-04-15 | Morphochem Ag Komb Chemie | Neue verbindungen mit antibakterieller aktivität |
EP1560488B1 (fr) | 2002-11-05 | 2010-09-01 | Glaxo Group Limited | Agents antibacteriens |
ES2340484T3 (es) | 2002-11-05 | 2010-06-04 | Glaxo Group Limited | Agentes antibacterianos. |
TW200427688A (en) | 2002-12-18 | 2004-12-16 | Glaxo Group Ltd | Antibacterial agents |
TW200507841A (en) | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
US7232833B2 (en) | 2003-03-28 | 2007-06-19 | Novexel | 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
DE10316081A1 (de) | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
US7348434B2 (en) | 2003-08-08 | 2008-03-25 | Antony Bigot | 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
FR2867472B1 (fr) | 2004-03-12 | 2008-07-18 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
WO2006002047A2 (fr) | 2004-06-15 | 2006-01-05 | Glaxo Group Limited | Agents antibacteriens |
FR2872164B1 (fr) | 2004-06-29 | 2006-11-17 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
EP1773831A1 (fr) | 2004-07-08 | 2007-04-18 | Glaxo Group Limited | Agents antibacteriens |
US20080194547A1 (en) | 2004-07-09 | 2008-08-14 | Glaxo Group Limited | Antibacterial Agents |
JP2008506695A (ja) | 2004-07-13 | 2008-03-06 | グラクソ グループ リミテッド | 抗細菌剤 |
JP2008507543A (ja) | 2004-07-22 | 2008-03-13 | グラクソ グループ リミテッド | 抗細菌剤 |
WO2006017468A2 (fr) | 2004-08-02 | 2006-02-16 | Glaxo Group Limited | Agents antibacteriens |
JP2008509222A (ja) | 2004-08-09 | 2008-03-27 | グラクソ グループ リミテッド | 抗菌剤 |
DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
CA2580621A1 (fr) | 2004-09-24 | 2006-03-30 | Actelion Pharmaceuticals Ltd | Nouveaux antibiotiques bicycliques |
WO2006038172A1 (fr) | 2004-10-05 | 2006-04-13 | Actelion Pharmaceuticals Ltd | Nouveaux antibiotiques de piperidine |
JP5314244B2 (ja) | 2004-10-27 | 2013-10-16 | 富山化学工業株式会社 | 新規な含窒素複素環化合物およびその塩 |
WO2006081182A2 (fr) | 2005-01-25 | 2006-08-03 | Glaxo Group Limited | Agents antibacteriens |
JP2008528604A (ja) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | 抗菌剤 |
JP2008528586A (ja) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | 抗菌剤 |
EP1845995A4 (fr) | 2005-01-25 | 2010-03-03 | Glaxo Group Ltd | Agents antibacteriens |
US7605169B2 (en) | 2005-01-25 | 2009-10-20 | Glaxo Group Limited | Antibacterial agents |
WO2006099884A1 (fr) | 2005-03-24 | 2006-09-28 | Actelion Percurex Ag | Antibiotiques beta-aminoalcools |
US7842810B2 (en) | 2005-03-31 | 2010-11-30 | Janssen Pharmaceutica, Nv | Bicyclic pyrazole compounds as antibacterial agents |
MX2007014507A (es) | 2005-05-24 | 2008-02-07 | Astrazeneca Ab | Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana. |
JP2008542258A (ja) | 2005-05-25 | 2008-11-27 | アクテリオン ファーマシューティカルズ リミテッド | 新規抗生物質誘導体 |
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
US8329694B2 (en) | 2005-06-24 | 2012-12-11 | Toyama Chemical Co., Ltd. | Quinoxalinones as antibacterial composition |
CA2626641A1 (fr) * | 2005-10-21 | 2007-07-19 | Glaxo Group Limited | Composes |
US20070185153A1 (en) | 2005-12-22 | 2007-08-09 | Nathalie Cailleau | Compounds |
ATE481406T1 (de) | 2006-04-06 | 2010-10-15 | Glaxo Group Ltd | Pyrrolochinoxalinonderivate als antibakterielle mittel |
JP2009532504A (ja) | 2006-04-06 | 2009-09-10 | グラクソ グループ リミテッド | 抗菌薬 |
GB0608263D0 (en) * | 2006-04-26 | 2006-06-07 | Glaxo Group Ltd | Compounds |
JP2009539807A (ja) | 2006-06-09 | 2009-11-19 | グラクソ グループ リミテッド | 抗菌薬としての置換1−メチル−1h−キノリン−2−オンおよび1−メチル−1h−1,5−ナフチリジン−2−オン |
GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
EP1992628A1 (fr) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Dérivés et analogues de N-éthylquinolones et N-éthylazaquinolones |
GB0705672D0 (en) * | 2007-03-23 | 2007-05-02 | Glaxo Group Ltd | Compounds |
EP1980251A1 (fr) | 2007-04-13 | 2008-10-15 | Glaxo Group Limited | Derivées de pyrrolo[3,2,1-ij]quinoline-4-one pour traiter la tuberculose |
GB0707708D0 (en) | 2007-04-20 | 2007-05-30 | Glaxo Group Ltd | Compounds |
GB0707706D0 (en) | 2007-04-20 | 2007-05-30 | Glaxo Group Ltd | Compounds |
EP2005995A1 (fr) | 2007-06-22 | 2008-12-24 | Glaxo Group Limited | Composés hétérocycliques pour le traitement de la tuberculose |
GB0800367D0 (en) | 2008-01-09 | 2008-02-20 | Glaxo Group Ltd | Compounds |
-
2008
- 2008-04-16 DE DE602008002912T patent/DE602008002912D1/de active Active
- 2008-04-16 AU AU2008240764A patent/AU2008240764C1/en active Active
- 2008-04-16 CA CA2684659A patent/CA2684659C/fr active Active
- 2008-04-16 JP JP2010503491A patent/JP5389013B2/ja active Active
- 2008-04-16 KR KR1020097024090A patent/KR101567096B1/ko active IP Right Grant
- 2008-04-16 EA EA200970987A patent/EA015821B1/ru not_active IP Right Cessation
- 2008-04-16 EP EP08749580A patent/EP2137196B1/fr active Active
- 2008-04-16 US US12/596,685 patent/US8389524B2/en active Active
- 2008-04-16 CN CN2008800213034A patent/CN101687887B/zh active Active
- 2008-04-16 MX MX2009011317A patent/MX2009011317A/es active IP Right Grant
- 2008-04-16 SI SI200830103T patent/SI2137196T1/sl unknown
- 2008-04-16 AT AT08749580T patent/ATE483717T1/de active
- 2008-04-16 NZ NZ579877A patent/NZ579877A/en unknown
- 2008-04-16 PT PT08749580T patent/PT2137196E/pt unknown
- 2008-04-16 PL PL08749580T patent/PL2137196T3/pl unknown
- 2008-04-16 BR BRPI0810064A patent/BRPI0810064B8/pt active IP Right Grant
- 2008-04-16 WO PCT/EP2008/054621 patent/WO2008128942A1/fr active Application Filing
- 2008-04-16 MY MYPI20094376A patent/MY149347A/en unknown
- 2008-04-16 DK DK08749580.0T patent/DK2137196T3/da active
- 2008-04-18 PE PE2008000682A patent/PE20090274A1/es active IP Right Grant
- 2008-04-18 CL CL200801122A patent/CL2008001122A1/es unknown
- 2008-04-18 AR ARP080101605A patent/AR066111A1/es active IP Right Grant
- 2008-04-18 UY UY31038A patent/UY31038A1/es active IP Right Grant
- 2008-04-18 TW TW097114042A patent/TWI431006B/zh active
-
2009
- 2009-09-24 IL IL201204A patent/IL201204A0/en active IP Right Grant
- 2009-10-09 DO DO2009000240A patent/DOP2009000240A/es unknown
- 2009-10-19 CO CO09116570A patent/CO6251368A2/es not_active Application Discontinuation
- 2009-10-21 MA MA32296A patent/MA31324B1/fr unknown
- 2009-11-20 CR CR11123A patent/CR11123A/es unknown
-
2010
- 2010-04-29 HK HK10104245.3A patent/HK1138000A1/xx unknown
- 2010-10-19 HR HR20100574T patent/HRP20100574T1/hr unknown
- 2010-11-24 CY CY20101101052T patent/CY1111248T1/el unknown
-
2015
- 2015-10-23 CR CR20150586A patent/CR20150586A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31324B1 (fr) | Composés contenant de l'azote tricyclique utilisés en tant qu'agents antibactériens | |
MA39211A1 (fr) | Composés tricycliques comme agents anti-cancers | |
TW200614996A (en) | Antiviral compounds | |
UA91688C2 (en) | Antiviral compounds | |
MX2009005461A (es) | N-oxidos de analogos de 4,5-epoxi-morfinano. | |
TW200626068A (en) | Active compounds for seed treatment | |
TW200716606A (en) | Chemical compounds | |
TW200800963A (en) | Chemical compounds | |
HK1113352A1 (en) | Chemical compounds | |
HK1114375A1 (en) | Chemical compounds | |
GB2430935A (en) | Tetrapeptide analogs | |
TNSN07383A1 (en) | 1-h-quinazoline-2,4-diones and their use as ampa-receptor ligands | |
TW200718422A (en) | 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same | |
MA31906B1 (fr) | Inhibiteurs de la replication du virus de limmunodeficience humaine | |
TW200626559A (en) | Anilino-pyrimidine analogs | |
MX2009013830A (es) | Compuestos antivirales. | |
UA98494C2 (uk) | Противірусні сполуки | |
RS20060129A (en) | /1,8/naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
SG173374A1 (en) | Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones | |
TW200801001A (en) | Compounds | |
GB0613208D0 (en) | Compounds | |
MX2010009269A (es) | Compuesto de benzodiazepina y composicion farmaceutica. | |
MX2010003541A (es) | Bloqueadores del canal de potasio de arilo novedosos y usos de los mismos. | |
TW200613317A (en) | Steroid prodrugs with androgenic action | |
DE602007007934D1 (en) | Imidazoazephinonverbindungen |